Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 3NIH 2NETWORK 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Uterine Cervical Neoplasms 9Squamous Cell Carcinoma of Head and Neck 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Oropharyngeal Neoplasms 6Small Cell Lung Carcinoma 4Nasopharyngeal Carcinoma 4Mesothelioma, Malignant 4Urinary Bladder Neoplasms 3Mouth Neoplasms 3Lymphoid Interstitial Pneumonia 3Laryngeal Neoplasms 3Carcinoma 3Adenocarcinoma of Lung 3Vaginal Neoplasms 2Triple Negative Breast Neoplasms 2Tongue Neoplasms 2Stomach Neoplasms 2Ovarian Neoplasms 2Hypopharyngeal Neoplasms 2Ganglioneuroblastoma 2Carcinoma, Transitional Cell 2Brenner Tumor 2Urethral Neoplasms 1Ureteral Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Solitary Fibrous Tumor, Pleural 1Sinonasal Squamous Cell Carcinoma 1Salivary Gland Neoplasms 1Resectable Intrahepatic Cholangiocarcinoma 1

Interventions

Cisplatin 12Irinotecan 10Specimen Handling 8Fluorouracil 8Oxaliplatin 7Magnetic Resonance Spectroscopy 6Trastuzumab 5Leucovorin 5Capecitabine 5Biopsy 5Neoadjuvant Therapy 4Docetaxel 4fludarabine 3Radiotherapy 3Paclitaxel 3Interleukin-12 Subunit p35 3Epirubicin 3Cyclophosphamide 3Chemotherapy, Adjuvant 3trastuzumab deruxtecan 2talazoparib 2bryostatin 1 2aldesleukin 2X-Rays 2Psychiatric Rehabilitation 2Platinum 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Microarray Analysis 2Magnetic Resonance Imaging 2MK 2206 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Stomach Neoplasms × Platinum × Clear all
NCT00062374 2017-07-06

Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction

National Cancer Institute (NCI)

Phase 2 Completed
55 enrolled 7 charts
Gastrointestinal

Stomach Neoplasms

NCT00253370 2014-11-24

Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer

National Cancer Institute (NCI)

Phase 2 Completed
44 enrolled 8 charts
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡